Aims: The purpose of this study was to report on the development of evidence-based practice guidelines.
Full texts were reviewed → Classification of study designs was made up of four systematic literature reviews, 16 randomized controlled trials, 10 cohort studies, one case-control study, eight cross-sectional studies, and two economic evaluation studies. Thirty-three were non-analytical studies or experts opinions. → Assessment tool of SIGN was used for methodological quality evaluation of those studies.
Step 1. Identification of the guidelines development scope
To identify of contents and scope that would be included in guidelines, the key clinical questions were taken from comments of 15 nurses, including 10 pediatric ward nurses and five neonatal ward nurses, all of whom had more than two years of clinical experience in their respective clinical ward.
Twenty-two clinical questions were formulated, based on practitioner experience, literature search in order to identify the scope of guidelines. The PICO (P; Patient or Problem, I; Intervention, C; Comparison, O; Outcome) form was used ("Establish of Guidelines development plan," 2010) to present clinical questions (Appendix 1).
Step 2. Assignment of evidence levels from studies
This step was consisted of three phases. Medical Subject Headings (MeSH) terms and text words were used according to the designed search strategy at phase 1. (Table 1 ). The following search sources were used to confirm the evidence about the clinical questions; PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane, Database of Abstracts of Reviews of Effects (DARE), Guidelines Clearing House (GCH), and The Joanna Briggs Institute, Bandolier and domestic engines. Total number of searched studies was 719. Next 124 studies were selected by confirming duplication. 98 studies were selected through title and abstract review. 74 studies were selected through second full text review (Figure 2 ). Their study designs were classified and then methodological quality was evaluated at phase 2. Two nurses pursuing a nursing master's degree evaluated methodological quality of the selected studies that excluded non-analytical studies and expert opinions using an assessment tool of SIGN. To ensure objectivity, they conducted in separate rooms. As a result, evaluation about three studies did not coincide, so that issues were discussed by another evaluator pursuing a nursing master's degree. There were different opinions about confused variables; using of antibiotics, sample size (RCT-11, RCT-9; Appendix 2-2), and blinded control (CS-29; Appendix 2-3). At phase 3, evidence levels from those studies were assigned using an 8 phase system of SIGN. 
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Recommendations from the evidence were graded according to SIGN grading system ("SIGN 50: A guidelines developer's handbook," 2008). The grade of recommendation is moved to 'A' from 'D' according to the evidence levels and a number of the supported studies.
Step 4. Draft guidelines
The recommendations and their grades were described in the draft guidelines.
Step 5. Experts' evaluation about the draft A group for draft guidelines evaluation was composed of experts regarding pediatric PIV therapy. In other words, seven practical experts and seven theoretical experts were selected; nurses who worked in pediatric wards, neonatal wards, pediatric emergency center and practitioners who administer and educate about intravenous therapy. The experts evaluated on adequacy, effectiveness, and application possibility of the recommendations using RAND corporation scale (Sachs GS, Printz DJ, Kahn DA, Carpenter D, & JP., 2005). The evaluation results using Fehring method were converted into a one-point scale; measurement of 1, 2, 3, 4, and/or 5 indicated respective points of 0. 0.25, 0.5, 0.75, and 1 (Fehring, 1987 Step 6. Modification of the draft Depending upon the aforementioned point of step 5, experts opinion analysis and literature review were conducted in order to modify uncertain recommendations.
Step 7. Definitive guidelines
The guidelines were consisted of three categories and 64 recommendations. They are nine recommendations before PIVC, 26 recommendations during PIVC, and 29 recommendations after PIVC.
Step 8. Verification of its validity
To evaluate validity of the definitive guidelines content, Tool of Appraisal of Guidelines for Research and Evaluation (AGREE) was used ("AGREE Korean version," 2001). And, experts consisted of six individuals with extensive theoretical knowledge regarding clinical guidelines: 1) one professor of nursing fundamentals 2) one infection control expert 3) one pediatrician 4) one pediatric orthopedic surgeon 5) two experts, both with Ph.Ds. in Nursing, with more than 15 years of clinical experience.
Results
Methodological Quality Assessment for Assignment of the Evidence Level
Step 2, The result of the methodological quality assessment using the assessment tool of SIGN became evidences level for clinical questions which were derived from the guidelines development scope of step 1.
Four systematic literature reviews, sixteen randomized controlled trials, ten prospective cohort studies, one case-control study, nine cross-sectional studies and two economic evaluation studies were evaluated (Appendix 2-1~2-5).
Decision of Recommendation Grade
The recommendations were graded by the tool of SIGN. The grade was assigned from 'A' to 'D' according to number of supported studies, evidence level and practical possibility.
Step 3, the numbers of A, B, C, and D were six, 22, 13, and 23, respectively.
Draft Guidelines Evaluation
Draft guidelines derived in step 4 were evaluated in step 5. The adequacy and effectiveness scores of below 0.60 were two; 1) Application of lidocaine cream or 1% lidocaine using needle-free jet injection prior to insertion. 2) When a peripheral catheter is inserted to lower extremities, patients over eight years old are examined about a risk of thrombophlebitis by a physician.
And a low application was four: 3) if PIV therapy was required for more than six days, peripherally inserted central vein or midline should be regarded as alternative methods 4) PIV detection using ultrasound or near-infrared imaging 5) to compensate for the vasoconstrictor effect of lidocaine, glyceryl trinitrate cream that expands blood vessels should be applied for 10 minutes before PIVC 6) clean gloves should be worn in order to protect practitioners (Tables 2~3). 
Modification of the Draft Guidelines
Step 6, the experts opinions about recommendations need to be deleted were as follows: 1) lidocaine cream or 1% lidocaine using needle-free jet injection causes blood vessels constriction, waiting period is needed after lidocaine application; such a process becomes more complicated if an insertion site should be changed, and then additional medical expenses are incurred 2) PIV detection using the ultrasound or near-infrared imaging was evaluated as an insufficient recommendation from a lack of awareness and evidence.
The experts opinions about recommendations need to be modified were as follows: 1) The prescription that allows low extremities to be inserted with PIV catheters for children ≥ eight years of age, the recommendation was so modified that risk factors would be described and any agreement/dissent was recorded.
2) The recommendation for a peripherally inserted central catheter or a midline catheter is limited by situations where there is a lack of professionals to perform the procedure. Therefore, the information was modified as professional staff training and validation of the staffing.
3) The recommendation was modified as the use of clean gloves would not always be required due to the difficulty of detecting a vein, except for cases where an infective disease of patient or hand injury of practitioner is suspected.
Definitive Guidelines Assessment
Step 7, the definitive guidelines were evaluated by the six experts using AGREE tool. The overall content validity of these guidelines scored 83% and the domain-specific scores were between 70-78% (Table 4) . 
Definitive Guidelines
Step 8, these guidelines consist of three categories and 64 recommendations were defined. The three categories consist of recommendation in, before, and after PIVC (Appendix 8-10).
Discussion
The success rate of PIVC using the new methods (Doniger et The recommendation regarding the transparent sterile dressing was included these guidelines, but expert evaluated it as relatively lower probability because additional medical payment was incurred if health care's policy did not permit using of that dressing. However, injection site observation through the transparent sterile dressing should be guaranteed in order to perform PIV catheter replacement depending on the patient's clinical symptoms.
The catheter replacement depending on patient's clinical symptoms shall reduce pain, stress, and tissue damage. So, practitioners could manage other interventions due to reduction in the PIVC time. In addition, medical cost savings can be expected through a reduction of PIV consumables. (Webster et al., 2010).
Conclusion
These practical guidelines were based on the clinical questions asked by practitioners who actually performed PIVC management, and the search strategy consisted with the phases of 3 was used to find evidence regarding the clinical questions. For the content validity of guidelines, twice evaluation processes were undergone by many relevant experts.
The number of recommendations grade "A" is six: 1) The formation of PIV injection team 2) Although skin is sterilized, if the skin is touched again by hands, the area is assumed to be contaminated 3) PIV Catheters should be re-placed only in cases of complications 4) The fluid set injected glucose and amino acid independently should not be replaced within 72 or 96 hours unless there is a special condition requiring it. 5) According to an increased number of peripherally injected medications, the complication rate shall be increased. 6) Risk of phlebitis shall be increased when irritating medication is injected. The recommendation graded "B" is twenty-two, "C" thirteen, and "D" twenty-three.
What This Paper Adds
Various nursing interventions are performed for peripheral catheterization. Also during the practice, practitioners may have many decisions-making in accordance with various conditions. At that time, these recommendations and its grades could be considered. The higher of a grade, the more accurate interventions should be performed although situations shall be different. 
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Appendix 2-3. Quality appraisal of cohort studies
Study topics included the comparative study of phlebitis and its factors in peripheral intravenous catheters (CS-21, CS-22, CS-23, CS-25, CS-26, CS-28, CS-30), the success rate of peripheral vein detection using ultrasound (CS-24), the contamination rate associated with the use of a peripheral intravenous catheter (CS-27), and comparison of peripheral intravenous and catheter-related complications occurring in the Emergency Room and in the general hospital environment (CS-29).
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Appendix 2-4. Quality appraisal of case-control studies and cross-sectional studies The topics were education and the performance of peripheral intravenous catheterization. Nine, cross-sectional studies (CSSs) were evaluated. CSS topics were regional differences in the management of peripheral intravenous catheters (CSS-33), inconsistent guidelines and the nursing practice regarding peripheral intravenous catheters (CSS-32), recognition of and performance for preventing peripheral intravenous complications (CSS-34), factors influencing peripheral intravenous catheter failure (CSS-35), peripheral intravenous catheter reinsertion factors (CSS-36, CSS-39, CSS-40), pain caused by peripheral intravenous insertion (CSS-37), and selective replacement of peripheral intravenous catheters (CSS-38).
Focused 3. Explain to the child and the caregivers who participate in the course of intravenous therapy how to take precautions. 3-1. For children younger than three years, it is effective to explain the course of intravenous therapy by using a real model as an example as they are unable to understand an example if an explanation is made through a dummy or other representative object. The explanation should be provided in simple and clear words. Gloves are not essential in order to ensure hand hygiene and when using the 'no-touch' technique (No touch after sterilization). However, it is necessary to wear clean gloves so as to protect the medical service provider if the child has an infectious disease or is there is a wound on the clinician's hand. 
4-3.
Before and after contacting a child as well as before wearing clean gloves, the correct hand hygiene should be performed. 5-2. In case of disinfection using iodine, the disinfectant performance is revealed after the medicine dries. Therefore, a timer capable of measuring the point in time that passes two minutes after applying the disinfectant, after which the catheter should be placed after it is dry.
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6-3.
When selecting an area for catheterization, it should start from the distal area of the upper-limb while selecting the area by moving to the proximal area rather than the area of the previous catheterization, in cases of re-catheterization. If the area is further distal than that of the previous catheterization, medicine may leak into the area where the previous catheter was removed. -As chemical phlebitis is caused by medicine, the speed of the medicine's injection should be reduced and properly diluted medicine should be injected. -To access edema, the patient's arms should be lifted and if the roundness around the catheter placement area is large and spreads to the sides when lit by a flashlight, it indicates stagnated solution under the skin. 3-3. Even in cases of medication injected using an infusion pump, there should be frequent monitoring. 0.88 (0.13) Recommendation details -As a certain amount of medicine is introduced through an infusion pump on a regular basis, a medication should be given periodically regardless of internal damage, even in cases of complication generation. As more medicine can be accumulated through the pressure introduced by an infusion pump, thus organ damage can thus be accelerated. 5. Explain how to monitor complications to the child or caregivers who maintain the peripheral intravenous injection. 5-1. The information needed to monitor the catheterized area should be provided to the caregivers and children who are able to communicate, so that they can immediately inform the medical experts if there is any problem related to the peripheral intravenous injection. 
